Search

Your search keyword '"Sbolli, G."' showing total 144 results
Start Over Author "Sbolli, G."
144 results on '"Sbolli, G."'

1. Missed treatment in an Italian HBV infected patients cohort: HBV RER

Author

Ferrari, C., Giuberti, T., Villa, E., Andreone, P., Pietrangelo, A., Abbati, G., Magnani, G., Massari, M., Verucchi, G., Cancellieri, C., Ricca Rosellini, S., Levantesi, F., Mazzella, G., Sacchini, D., Fornaciari, G., Mussini, C., Borghi, V., Foschi, F., Libanore, M., Carradori, S.D., Contini, C., Ballardini, G., Macchia, S., Boccia, S., Vandelli, C., Bassi, P., Zanotti, M., Loria, P., Sbolli, G., Fornari, F., di Maira, P.V., Bellentani, S., Arlotti, M., Grosso, C., Bolondi, G., Pazzi, P., Mazzocchi, A., Govoni, A., Fusaroli, P., Giacomoni, P.L., Lenzi, M., Pedretti, G., Cuomo, Gianluca, Borghi, Vanni, Andreone, Pietro, Massari, Marco, Villa, Erica, Pietrangelo, Antonello, Verucchi, Gabriella, and Ferrari, Carlo

Published
2016
Full Text
View/download PDF

7. Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma

Author

Tanzi, E., primary, Galli, C., additional, Delaito, M., additional, Bertin, T., additional, Pizzocolo, G., additional, Rodella, A., additional, Buscarini, L., additional, Sbolli, G., additional, Rossi, U., additional, Romano, L., additional, Chiaramonte, M., additional, and Zanetti, Alessandro R., additional

Published
1992
Full Text
View/download PDF

9. Missed treatment in an Italian HBV infected patients cohort: HBV RER

Author

Cuomo, Gianluca, primary, Borghi, Vanni, additional, Andreone, Pietro, additional, Massari, Marco, additional, Villa, Erica, additional, Pietrangelo, Antonello, additional, Verucchi, Gabriella, additional, Ferrari, Carlo, additional, Ferrari, C., additional, Giuberti, T., additional, Villa, E., additional, Andreone, P., additional, Pietrangelo, A., additional, Abbati, G., additional, Magnani, G., additional, Massari, M., additional, Verucchi, G., additional, Cancellieri, C., additional, Ricca Rosellini, S., additional, Levantesi, F., additional, Mazzella, G., additional, Sacchini, D., additional, Fornaciari, G., additional, Mussini, C., additional, Borghi, V., additional, Foschi, F., additional, Libanore, M., additional, Carradori, S.D., additional, Contini, C., additional, Ballardini, G., additional, Macchia, S., additional, Boccia, S., additional, Vandelli, C., additional, Bassi, P., additional, Zanotti, M., additional, Loria, P., additional, Sbolli, G., additional, Fornari, F., additional, di Maira, P.V., additional, Bellentani, S., additional, Arlotti, M., additional, Grosso, C., additional, Bolondi, G., additional, Pazzi, P., additional, Mazzocchi, A., additional, Govoni, A., additional, Fusaroli, P., additional, Giacomoni, P.L., additional, Lenzi, M., additional, and Pedretti, G., additional

Published
2016
Full Text
View/download PDF

14. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon

Author

Fattovich, G., Giustina, G., Favarato, S., Ruol, A., Macarri, G., Orlandi, E., Iaquinto, G., Ambrosone, L., Francavilla, A., Pastore, G., Santantonio, M. T., Romagno, D., Bolondi, L., Sofia, S., Marchesini, A., Pisi, E., Mazzella, G., Roda, E., Attaro, L., Chiodo, E., Mori, E., Verucchi, G., Lanzini, A., Salmi, A., Calvi, B., Bozzetti, E., Radaeli, E., Bernasconi, M., Pilleri, G., Bacca, D., Romano, G., Mastrapasqua, G., Cozzolongo, R., Cacopardo, B., Nunnari, A., Blasi, A., Sala, L. O., Minoli, G., Sangiovanni, A., Spinzi, G. C., Colombo, A., Camassa, M., Riva, D., Maggi, G., Boccia, S., Gualandi, G., Nucci, A., Pacini, F., Marino, N., Mazzotta, E., La Mura, A., Pompei, A. G., Casinelli, K., Petrosillo, N., Giacchino, R., Timitilli, A., Spiga, E., Corsetti, M., Menicagli, V., Tucci, A., Bissoli, E., Raimondo, G., Rodino, G., Bellobuono, A., Ideo, G., Colombo, M., Pacchetti, S., Rumi, M. R., Battezzati, P. M., Bruno, S., Podda, M., Zuin, M., Fargion, S., Fiorelli, G., Gellmann, E., Vandelli, C., Ventura, E., Manenti, F., Villa, E., Caporaso, N., Coltorti, M., Morisco, E., Del Vecchio-Blanco, C., di Santolo, S. S., Di Nunzio, S., Ruggiero, G., Zampino, R., Ascione, A., De Luca, M., Galeota-Lanza, A., Aprea, L., Sagnelli, E., Felaco, E. M., Piccinino, E., Ballare, M., Monteverde, A., Tappero, G., Sanna, G., Alberti, A., Bonetti, P., Casarin, C., Diodati, G., Tremolada, E., Naccarato, R., Chiaramonte, M., Floreani, M. R., Almasio, P., Craxi, A., Loiacono, O., Pagliaro, L., Fiaccadori, E., Giuberti, T., Belloni, G., Bernardini, E., Buscarini, L., Sbolli, G., Giudici-Cipriani, A., Marenco, G., Mazzaro, C., Massari, M., Fornaciari, G., Plancher, A., Gasbarrini, G., Grieco, A., Luchetti, R., Rapaccini, G. L., Bombardieri, G., Di Virgilio, D., Bruno, G., Ricci, G. L., Hassan, G., Mari, T., Scalisi, I., Colloredo, G., Frunzio, A., Tabone, M., Costa, C., Rosina, E., Saracco, G., Verme, G., Frezza, M., Urban, E., Capra, E., Casaril, M., Corrocher, R., and Benetti, G. P.

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Hepatitis, Viral, Human, Alpha interferon, Poison control, Chronic viral hepatitis, Interferon alfa, Side effects, Gastroenterology, Autoimmune Diseases, Internal medicine, Medicine, Humans, Adverse effect, Child, Aged, Retrospective Studies, Hepatitis, Hepatology, business.industry, Thyroid disease, Mental Disorders, Infant, Newborn, Infant, Middle Aged, medicine.disease, Recombinant Proteins, Surgery, Bone marrow suppression, Child, Preschool, Chronic Disease, Interferon Type I, Female, business, Viral hepatitis, medicine.drug
Abstract

Aims: The aim of this study was to assess the incidence of fatal, life-threatening side effects and the de novo appearance of non-hepatic morbidity during interferon alfa therapy for chronic viral hepatitis. The relationship of these adverse events to actual total dose and duration of interferon was also evaluated. Methods: We conducted a retrospective study at 73 Italian centers of 11 241 consecutive patients with chronic vital hepatitis who underwent interferon alfa treatment. Results: Five patients died during interferon therapy due to liver failure ( n =4) or complications arising from sepsis. Life-threatening side effects were observed in eight patients: two cases where depression developed and led to a suicide attempt and six patients with bone marrow suppression (granulocytes 3 or platelets 3 ). These symptoms and signs completely disappeared after interferon withdrawal. During interferon treatment, 131 patients developed the following de novo non-hepatic disorders: symptomatic thyroid disease ( n =71), impotence ( n =5), systemic autoimmune disease ( n =5), immune-mediated dermatologic disease ( n =14), diabetes mellitus ( n =10), cardiovascular disease ( n =7), psychosis n =10), seizures ( n =4), peripheral neuropathy ( n =3) and hemolytic anemia ( n =2). Most of these complications are reversible or can be ameliorated. Fatal or life-threatening side effects were not related to actual total dose or duration of interferon alfa, while the majority of patients with de novo non-hepatic morbidity received medium/high doses ( > 200 million units) of interferon alfa or were treated for periods longer than 16 weeks (68% and 80%, respectively). Conclusions: Treatment with interferon alfa may have fatal or life-threatening side effects, their incidence in this study being low (0.04% and 0.07%, respectively) and perhaps no different than in untreated patients with chronic viral hepatitis. Moreover de novo non-hepatic morbidity occurred in 1.2% of patients, and the dose and duration of interferon therapy seem important in determining the frequency of this complication. The development of clinically-overt thyroid disease was most common.

Published
1996

17. OC.03.5 ECHOGRAPHIC DETECTION OF HEPATOCELLULAR CARCINOMA (HCC) DURING FOLLOW UP IN CIRRHOTIC PATIENTS WITH PREVIOUS HCC. COMPARISON AMONG US, CT AND A NEW PANORAMIC 3-DIMENSIONAL CONTRAST-ENHANCED US WITH NAVIGATOR SYSTEM (3-D NAV CEUS)

Author

Giangregorio, F., primary, Marinone, M., additional, Aragona, G., additional, Comparato, G., additional, Fanigliulo, L., additional, Sbolli, G., additional, Di Stasi, M., additional, Tansini, P., additional, and Fornari, F., additional

Published
2010
Full Text
View/download PDF

21. OC2.01.6 ECHOGRAPHIC DETECTION OF NEW HCCS IN CIRRHOTIC PATIENTS (PREVIOUSLY TREATED WITH MULTIPLE TECHNIQUES): COMPARISON AMONG CONVENTIONAL US, SPIRAL CT AND 3-DIMENSIONAL CONTRAST-ENHANCED US WITH NAVIGATOR TECHNIQUE (3DNAV CEUS)

Author

Giangregorio, F., primary, Comparato, G., additional, Fanigiulo, L., additional, Sbolli, G., additional, Di Stasi, M., additional, Marinone, G., additional, Tansini, P., additional, Aragona, G., additional, and Fornari, F., additional

Published
2008
Full Text
View/download PDF

36. Laparoscopic ultrasonography in the study of liver diseases. Preliminary results.

Author

Fornari, F, Civardi, G, Cavanna, L, Sbolli, G, Rossi, S, Di Stasi, M, Buscarini, E, and Buscarini, L

Subjects
CIRRHOSIS of the liver, LIVER tumors, HEPATOCELLULAR carcinoma, ENDOSCOPES, ULTRASONIC imaging, DIAGNOSIS
Abstract

In this report we present our preliminary experience using a recently developed sonolaparoscope. The 7.5 MHz rotating transducer, fixed to the tip of the laparoscope, produces a sector scan display of 180 degrees. We have used this technique in nine patients: five with cirrhosis and four with focal lesions of the liver. Laparoscopic sonography (LS) visualized two small nodular lesions in two cases of cirrhosis that did not show up with conventional ultrasonography (US). In one case of small hepatocellular carcinoma (HCC) located in the seventh hepatic segment, the lesion was not revealed. The ultrasound patterns of cirrhosis, hepatic cyst, and hemangioma were typical. We also performed ultrasonically guided biopsies. We concluded that laparoscopic sonography may be useful in the study of cirrhosis and in oncological patients for the screening of small hepatic lesions and that it could, in future, represent a preoperative step for liver surgery. [ABSTRACT FROM AUTHOR]

Published
1989
Full Text
View/download PDF

50. Clinical and histological correlation in non lymphoma (NHL) with hepatitis C virus (HCV) markers

Author

Vallisa, D., Berte, R., Giangregorio, F., Civardi, G., Ferrari, B., Rocca, A., Sbolli, G., and Cavanna, L.

Subjects
Complications and side effects, Non-Hodgkin lymphomas -- Complications and side effects, Hepatitis C -- Complications and side effects, Non-Hodgkin's lymphomas -- Complications and side effects
Abstract

'Clinical and Histological Correlation in Non Lymphoma (NHL) with Hepatitis C Virus (HCV) Markers.' D. Vallisa, R. Berte, F. Giangregorio, G. Civardi, B. Ferrari, A. Rocca, G. Sbolli and L. [...]

Published
1997

Catalog

Books, media, physical & digital resources
See catalog results